Jump to content

Talk:JMA Journal

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Cewbot (talk | contribs) at 19:03, 15 February 2024 (Maintain {{WPBS}}: 3 WikiProject templates. Keep majority rating "Start" in {{WPBS}}. Remove 1 same rating as {{WPBS}} in {{WikiProject Japan}}. Keep 1 different rating in {{WikiProject Medicine}}.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Notability, primar/secondary sources, verification

The journal is the main English publication for the JMA and WMA (Asia) region, and is used for the announcements and scholarly articles described in the article. Journal articles are by author invitation only allowijg the editors to control the importance and quality of the articles. Novel clinical and groundbreaking research is published by the journal but usually not as the first port of call for the authors. For example groundbreaking genetic therapy research conducted by a JMA member is likely to be published in the Lancet first, and then the author may be invited to write a followup article for the JMAJ. This is why impact factors for the JMAJ are low, and secondary sources to cite in this WP article are few. — Preceding unsigned comment added by Dr.khatmando (talkcontribs) 10:38, 11 May 2017 (UTC)[reply]